Integrated Filing — IndAS



General information about company

Scrip Code 543252
NSE Symbol FAIRCHEMOR
MSEI Symbol NOTLISTED
ISIN INE0DNW01011
Name of company Fairchem Organics Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 27-07-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 13-07-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment Speciality Chemicals
Start date and time of board meeting 27-07-2026   11:40:00
End date and time of board meeting 27-07-2026   12:35:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 17,614.57 17,614.57
Other income 34.75 34.75
Total income 17,649.32 17,649.32
2 Expenses
(a) Cost of materials consumed 12,026.54 12,026.54
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 1,598.10 1,598.10
(d) Employee benefit expense 675.40 675.40
(e) Finance costs 183.79 183.79
(f) Depreciation, depletion and amortisation expense 274.00 274.00
(f) Other Expenses
1 Power and Fuel 698.15 698.15
2 Other Expenses 829.67 829.67
Total other expenses 1,527.82 1,527.82
Total expenses 16,285.65 16,285.65
3 Total profit before exceptional items and tax 1,363.67 1,363.67
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,363.67 1,363.67
6 Tax expense
7 Current tax 359.79 359.79
8 Deferred tax 2.50 2.50
9 Total tax expenses 362.29 362.29
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,001.38 1,001.38
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,001.38 1,001.38
17 Other comprehensive income net of taxes (38.37) (38.37)
18 Total Comprehensive Income for the period 963.01 963.01
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,259.59 1,259.59
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.95 7.95
Diluted earnings (loss) per share from continuing operations 7.95 7.95
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.95 7.95
Diluted earnings (loss) per share from continuing and discontinued operations 7.95 7.95
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: 1. The above unaudited financial results, as reviewed by Audit Committee, are subsequently approved by the Board of Directors at their meetings held on July 27, 2026. The Statutory Auditors have performed limited review of the Company's financial results for the quarter ended June 30, 2026. The Statutory Auditors have expressed an unmodified review conclusion. 2. The unaudited financial results of the Company have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and in terms of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 3. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year and the year to date unaudited figures up to the third quarter for that year. Also, the figures up to the end of third quarter had only been reviewed and not subjected to audit. 4. The Company is engaged in the business of manufacturing of speciality chemicals viz. Oleo Chemicals and Intermediate Nutraceuticals. Considering the nature of Company’s business, as well as based on review of operating results by the chief operating decision maker to make decisions about resource allocation and performance measurement, there is only one reportable business segment in accordance with the requirements of IND AS 108 – “Operating Segments”. As almost all the revenue of the Company is from domestic sales, no separate geographical segment is disclosed. (Rs. In Lakhs) Particulars Quarter ended Year ended 30-June-2026 31-Mar-2026 30-June-2025 31-Mar-2026 Unaudited Audited Unaudited Audited I Segment Revenue Speciality Chemicals 17,614.57 11,692.84 13,106.31 45,964.82 II Segment Results Speciality Chemicals 1,547.46 552.40 261.68 1,153.96 Less: Finance cost (183.79) (112.01) (100.52) (369.66) Add: Interest Income - 32.81 0.40 35.98 Profit Before Tax and Exceptional Items 1,363.67 473.19 161.56 820.27 Less: Exceptional Items (Note 6) - - - (88.27) Profit Before Tax 1,363.67 473.19 161.56 732.00 III Segment Assets Speciality Chemicals 39,751.56 39,097.93 36,189.52 39,097.93 IV Segment Liabilities Speciality Chemicals 12,484.50 12,793.90 5,875.54 12,793.90 5. The Company does not have any subsidiary/associate/joint venture company as on June 30, 2026. 6. The Government of India has implemented four new Labour Codes, including the Codes on Wages,2019 w.e.f. November 21, 2025. Based on management’s assessment, actuarial valuation and in line with ICAI guidance, the Company has recognised additional employee benefit obligation of Rs.88.27 Lakhs and considering the event as regulatory-driven and nonrecurring in nature, the impact of the same has been disclosed under exceptional items in the financial results for the year ended 31 March 2026. 7. The Board of Directors at its meeting held on November 20, 2025 passed a resolution to buyback upto 4,25,000 Equity Shares of Rs. 10/- each fully paid-up, representing 3.26% of the total number of pre-buyback equity shares of the Company as at March 31, 2025, through a Tender Offer route, at a price of Rs. 800/- (Rupees Eight Hundred only), payable in cash, for an aggregate amount not exceeding Rs. 34 Crores, excluding any expenses or transaction costs incurred or to be incurred for the Buyback. Thereafter, the Members of the Company through Postal Ballot approved the Special Resolution on December 26, 2025. Accordingly, the Buyback offer was commenced on January 8, 2026 and closed on January 14, 2026. Pursuant to and in compliance with the provisions of Section 68 of the Companies Act, 2013 read with Rule 17 of the Companies (Share Capital and Debentures) Rules, 2014 and the Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018, the settlement of all valid bids was completed on January 21, 2026 and 4,25,000 Equity Shares, which were tendered and accepted in Buyback were extinguished on January 27, 2026. 8. Investors can view the unaudited financial results of the company for the quarter ended June 30, 2026 on the company's website www.fairchem.in, on the website of the BSE www.bseindia.com and on the website of NSE www.nseindia.com. For and on behalf of the Board of Directors, For, Fairchem Organics Limited Place: Chekhala, Taluka Sanand, Dist. AHMEDABAD Nahoosh Jariwala Date: July 27, 2026 Chairman and Managing Director (DIN: 00012412)



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement (losses)/Gains on Post Employment Defined Benefit Plans (51.28) (51.28)
2 Income Tax effect 12.91 12.91
Total Amount of items that will not be reclassified to profit and loss (38.37)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (38.37) (38.37)





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 B S R and Co Yes 30-04-2029